AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 43(2), 1990, pp. 146-158
Copyright © 1990 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teixeira, A. R. L.
Right arrow Articles by Solórzano, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teixeira, A. R. L.
Right arrow Articles by Solórzano, E.

Chagas' Disease: Lymphoma Growth in Rabbits Treated with Benznidazole

Antônio R. L. Teixeira, José Carlos Córdoba, Inês Souto Maior AND Edwin Solórzano
University of Brasília, Brasília, Brazil

Administration of the trypanocidal drug, Benznidazole (N-benzyl-2-nitroimidazoleacetamide) to Trypanosoma cruzi-infected rabbits did not arrest the destructive Chagas' heart myocarditis. A typical feature of lymphocytic infiltrates associated with non-parasitized heart cell lysis was present in both treated and untreated groups of rabbits. Benznidazole-treated rabbits had their survival time shortened, probably as a consequence of Chagas' heart disease and of the development of lymphomas. The survival time of untreated T. cruzi-infected rabbits was 765 ± 639 days and those treated with Benznidazole in the chronic phase of infection survived for 392 ± 571 days. Malignant, non-Hodgkin's lymphomas were present in 38% of the rabbits that received the nitroarene therapy. Testicular atrophy was observed in 2 out of 10 nitroarene-treated rabbits. Benznidazole administration caused severe cell-mediated immunosuppression in T. cruzi-infected and BCG-immunized rabbits. Specific antibodies against the parasite and an unrelated antigen were detected in high levels, regardless of the nitroarene administration.




This article has been cited by other articles:


Home page
JAMAHome page
C. Bern, S. P. Montgomery, B. L. Herwaldt, A. Rassi Jr, J. A. Marin-Neto, R. O. Dantas, J. H. Maguire, H. Acquatella, C. Morillo, L. V. Kirchhoff, et al.
Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review
JAMA, November 14, 2007; 298(18): 2171 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A R L Teixeira, N Nitz, M C Guimaro, C Gomes, and C A Santos-Buch
Chagas disease
Postgrad. Med. J., December 1, 2006; 82(974): 788 - 798.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
J. A Castro, M. M. deMecca, and L. C Bartel
Toxic Side Effects of Drugs Used to Treat Chagas' Disease (American Trypanosomiasis)
Human and Experimental Toxicology, August 1, 2006; 25(8): 471 - 479.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Society of Tropical Medicine and Hygiene.